BUY
Has run into problems with US health agencies getting them to pay for the product. Should do OK.
TOP PICK
(Was a top pick on July 3. Down 30%) Still likes. Has dropped because of drop in sector.
PAST TOP PICK
(Was a top pick on July 3. Down 8%) Still likes. Dividend.
PAST TOP PICK
(Was a top pick on July 3. Down 6%) Still likes. Great management.
TOP PICK
TOP PICK
Bargain price.
TOP PICK
BUY
A bit of gold is good to have in a portfolio.
TOP PICK
Has done well. Expects housing should continue to do well.
BUY
Good technology. Some potential. Good clients. No free cash flow. Speculative.
DON'T BUY
Limited pipeline. Trying to expand. Has limited downside, but not much upside either.
TOP PICK
Free cash flow. Strong earnings. Good growth.
DON'T BUY
Facing a lot of potential liabilities.
WEAK BUY
Lots of opportunities. Should do well in the long term.
DON'T BUY
Clients are limiting spending.